Crafting a Smarter Future for Stroke Diagnosis

Dr. Michalis Papadakis is the CEO and Co-founder of Brainomix, a Scale Up Cohort 1 member and a healthtech company that specializes in AI-powered imaging software for stroke diagnosis. With Dr. Papadakis’s guidance, Brainomix has grown from inception, to securing over $30 million in private investment and public funding.

With more than a decade of academic experience, Dr. Papadakis earned his BSc in Biochemistry from Imperial College London. He later obtained a PhD in Neurosciences from the UCL School of Pharmacy, where he conducted research on cerebral ischemia at the University of Oxford, also serving as the Scientific Director of the preclinical stroke lab. Now leading Brainomix, Dr. Papadakis is applying AI innovation to stroke care, helping to save lives and improve patient outcomes worldwide.

Prior to founding Brainomix, Dr. Papadakis served as a post-doctoral research fellow at the University of Calgary and the UCL School of Pharmacy. He also held the position of post-doctoral research fellow and scientific director at the University of Oxford. As the Laboratory’s Scientific Director, he conceived, designed, and carried out a comprehensive research study, which identified a novel neuroprotective target for strokes, and went on to publish nine peer-reviewed papers.